Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genomic typing for patient-specific human leukocyte antigen-alleles is an efficient tool for relapse detection of high-risk hematopoietic malignancies after stem cell transplantation from alternative donors.
Mazzi B, Clerici TD, Zanussi M, Lupo Stanghellini MT, Vago L, Sironi E, Peccatori J, Bernardi M, Carrera P, Palini A, Rossini S, Bordignon C, Bonini C, Ferrari M, Ciceri F, Fleischhauer K. Mazzi B, et al. Among authors: peccatori j. Leukemia. 2008 Nov;22(11):2119-22. doi: 10.1038/leu.2008.98. Epub 2008 May 1. Leukemia. 2008. PMID: 18449202 No abstract available.
Younger unrelated donors may be preferable over HLA match in the PTCy era: a study from the ALWP of the EBMT.
Sanz J, Labopin M, Choi G, Kulagin A, Peccatori J, Vydra J, Reményi P, Versluis J, Rovira M, Blaise D, Labussière-Wallet H, Montoro J, Sica S, Meijer E, Itälä-Remes M, Schaap N, Bulabois CE, Piemontese S, Mohty M, Ciceri F. Sanz J, et al. Among authors: peccatori j. Blood. 2024 Jun 13;143(24):2534-2543. doi: 10.1182/blood.2023023697. Blood. 2024. PMID: 38657278
Incidence of human cytomegalovirus infection in patients with refractory solid tumors receiving nonmyeloablative allogeneic stem cell transplants versus recipients of standard SCT for hematologic malignancies.
Zambelli A, Lilleri D, Pedrazzoli P, Peccatori J, Baldanti F, Fregoni V, Ciceri F, Caldera D, Renga M, Colombo AA, Alessandrino EP, Gerna G, Da Prada GA, Siena S, Bregni M. Zambelli A, et al. Among authors: peccatori j. Biol Blood Marrow Transplant. 2005 Jun;11(6):423-8. doi: 10.1016/j.bbmt.2005.02.005. Biol Blood Marrow Transplant. 2005. PMID: 15931630 Free article. Clinical Trial.
Bone marrow mammaglobin expression as a marker of graft-versus-tumor effect after reduced-intensity allografting for advanced breast cancer.
Bregni M, Fleischhauer K, Bernardi M, Pescarollo A, Guggiari E, Lunghi F, Deola S, Scaramuzza S, Re F, Setola E, Monari M, Mazzi B, Servida P, Corradini P, Peccatori J. Bregni M, et al. Among authors: peccatori j. Bone Marrow Transplant. 2006 Feb;37(3):311-5. doi: 10.1038/sj.bmt.1705248. Bone Marrow Transplant. 2006. PMID: 16400340
Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation.
Ciceri F, Bonini C, Marktel S, Zappone E, Servida P, Bernardi M, Pescarollo A, Bondanza A, Peccatori J, Rossini S, Magnani Z, Salomoni M, Benati C, Ponzoni M, Callegaro L, Corradini P, Bregni M, Traversari C, Bordignon C. Ciceri F, et al. Among authors: peccatori j. Blood. 2007 Jun 1;109(11):4698-707. doi: 10.1182/blood-2006-05-023416. Epub 2007 Feb 27. Blood. 2007. PMID: 17327416 Free article.
Pre-transplant 18FDG-PET predicts outcome in lymphoma patients treated with high-dose sequential chemotherapy followed by autologous stem cell transplantation.
Crocchiolo R, Canevari C, Assanelli A, Lunghi F, Tassara M, Stanghellini ML, Clerici D, Landoni C, Servida P, Bernardi M, Peccatori J, Ferreri A, Gianolli L, Bordignon C, Caligaris-Cappio F, Ciceri F, Fazio F. Crocchiolo R, et al. Among authors: peccatori j. Leuk Lymphoma. 2008 Apr;49(4):727-33. doi: 10.1080/10428190701885545. Leuk Lymphoma. 2008. PMID: 18398740
Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation.
Vago L, Forno B, Sormani MP, Crocchiolo R, Zino E, Di Terlizzi S, Lupo Stanghellini MT, Mazzi B, Perna SK, Bondanza A, Middleton D, Palini A, Bernardi M, Bacchetta R, Peccatori J, Rossini S, Roncarolo MG, Bordignon C, Bonini C, Ciceri F, Fleischhauer K. Vago L, et al. Among authors: peccatori j. Blood. 2008 Oct 15;112(8):3488-99. doi: 10.1182/blood-2007-07-103325. Epub 2008 Jul 21. Blood. 2008. PMID: 18645039 Free article.
135 results